NextGen Healthcare, Inc. (NASDAQ:NXGN) Given Consensus Rating of “Buy” by Analysts

Shares of NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) have received an average recommendation of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, three have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $22.17.

NXGN has been the subject of a number of research reports. Piper Sandler boosted their target price on shares of NextGen Healthcare from $23.00 to $24.00 in a research report on Wednesday, January 26th. Zacks Investment Research downgraded shares of NextGen Healthcare from a “hold” rating to a “sell” rating and set a $21.00 target price for the company. in a research report on Thursday, May 5th. Guggenheim upgraded shares of NextGen Healthcare from a “neutral” rating to a “buy” rating and set a $26.00 target price for the company in a research report on Friday, May 6th. Finally, StockNews.com initiated coverage on shares of NextGen Healthcare in a research report on Thursday, March 31st. They set a “strong-buy” rating for the company.

NXGN stock opened at $19.26 on Wednesday. NextGen Healthcare has a 12-month low of $13.64 and a 12-month high of $21.87. The stock’s 50 day simple moving average is $20.27 and its 200 day simple moving average is $18.54. The stock has a market capitalization of $1.29 billion, a PE ratio of 1,927.93, a price-to-earnings-growth ratio of 5.57 and a beta of 1.17.

In other NextGen Healthcare news, CAO David Ahmadzai sold 6,250 shares of the company’s stock in a transaction dated Tuesday, March 15th. The shares were sold at an average price of $19.55, for a total value of $122,187.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Donna Cullen Greene sold 63,625 shares of the company’s stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $20.05, for a total transaction of $1,275,681.25. The disclosure for this sale can be found here. In the last quarter, insiders sold 144,551 shares of company stock valued at $2,896,091. Insiders own 18.70% of the company’s stock.

Several institutional investors have recently modified their holdings of the business. Advisor Group Holdings Inc. increased its stake in shares of NextGen Healthcare by 12.0% during the fourth quarter. Advisor Group Holdings Inc. now owns 5,127 shares of the company’s stock worth $92,000 after purchasing an additional 548 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of NextGen Healthcare by 2.2% during the fourth quarter. Louisiana State Employees Retirement System now owns 27,800 shares of the company’s stock worth $495,000 after purchasing an additional 600 shares in the last quarter. Maryland State Retirement & Pension System increased its stake in shares of NextGen Healthcare by 3.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 22,901 shares of the company’s stock worth $407,000 after purchasing an additional 780 shares in the last quarter. Teacher Retirement System of Texas increased its stake in shares of NextGen Healthcare by 8.0% during the first quarter. Teacher Retirement System of Texas now owns 11,939 shares of the company’s stock worth $250,000 after purchasing an additional 886 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its stake in shares of NextGen Healthcare by 2.4% during the fourth quarter. Thrivent Financial for Lutherans now owns 46,749 shares of the company’s stock worth $832,000 after purchasing an additional 1,077 shares in the last quarter. Institutional investors and hedge funds own 71.15% of the company’s stock.

About NextGen Healthcare (Get Rating)

NextGen Healthcare, Inc provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions.

Read More

Analyst Recommendations for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.